A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.

医学 内科学 B组 前瞻性队列研究 酊剂(纹章学) 胃肠病学 外科 传统医学
作者
Chen Lm,Cong Qi,Deqing Wu,Pei‐Jer Chen,Lugui Qiu,Zhi-Jie Hong,Ying Yang,Xu Liu,Wang Lf,Li Huang,W-R Li,Jiyu Tang,Yongli Cao,Lu-Lu Sui
出处
期刊:PubMed 卷期号:27 (19): 8985-8992
标识
DOI:10.26355/eurrev_202310_33922
摘要

The aim of the study was to investigate the safety and antiviral efficacy of a Chinese multiherb extract-based tincture (GWK) on a population of patients with high-risk human papilloma (hrHPV) infections and hrHPV-caused cervical low-grade squamous intraepithelial lesions (LSILs).Patients with persistent hrHPV infection were enrolled in Group A, including A1 subjects, who received the intervention, and A2 subjects, who received the control. Patients with hrHPV infection causing cervical LSIL were enrolled in Group B, which included B1 subjects, who received the intervention, and B2 subjects, who served as the control. For Groups A1 and B1, hrHPV was tested at 3 months (M3) and 6 months (M6) after the intervention. The side effects were also analyzed.At baseline (D0), a total of 99 patients were enrolled in Group A, with 50 subjects in Group A1 and 49 subjects in Group A2. A total of 91 patients were enrolled in Group B, with 45 subjects in Group B1 and 46 subjects in Group B2. There was no significant difference in the characteristics, including average age, age stratification, and HPV genotype. At M6, both Group A1 and Group B1 had a higher hrHPV clearance rate than the control group (A1/A2: 80.0% vs. 20.4%; B1/B2: 64.4% vs. 15.2%, p<0.001). At M6, the effective rates of Group A1 and Group B1 were 84% (42/50) and 68.9% (31/45), respectively. The side effect rates of Groups A1 and B1 were 11.5% (6/52) and 11.1% (5/45), respectively. Most adverse reactions involved local discomfort, including vulvar erythema, vulvar itch, increased vaginal discharge, cervical bleeding, and mild pain in the lower abdomen. Univariate logistic regression analysis showed that the intervention had an OR of 12 (95% CI 4.431-32.50) for clearing persistent HPV infection (p<0.001). For cervical LSIL, the intervention had an OR of 10.1 for clearing persistent HPV infection (95% CI 3.68-27.7) (p<0.001).The results of this study suggest that the Chinese multiherb extract-based tincture GWK is safe and well tolerated. Furthermore, this preliminary study showed that this Chinese multiherb extract-based tincture is helpful for promoting HPV clearance in cases of persistent HPV and HPV-induced LSIL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
温暖半雪发布了新的文献求助10
1秒前
CodeCraft应助RedBoy采纳,获得10
1秒前
lgy完成签到,获得积分10
2秒前
淡淡的凤关注了科研通微信公众号
2秒前
zhang发布了新的文献求助10
2秒前
科研通AI6.2应助冬1采纳,获得10
3秒前
云间客发布了新的文献求助30
3秒前
3秒前
英姑应助mxdckd采纳,获得10
4秒前
麻瓜完成签到,获得积分10
4秒前
陈丽君完成签到,获得积分10
5秒前
cdercder应助yy采纳,获得10
5秒前
风清扬发布了新的文献求助10
5秒前
better完成签到 ,获得积分10
6秒前
苗雅宁完成签到,获得积分10
7秒前
华仔应助小巧的师采纳,获得10
8秒前
希望天下0贩的0应助妮妮采纳,获得10
9秒前
kenyant完成签到,获得积分10
10秒前
10秒前
自由的半雪应助Lny采纳,获得50
10秒前
orixero应助RedBoy采纳,获得10
12秒前
wanci应助古渡采纳,获得50
12秒前
12秒前
应用1完成签到,获得积分10
12秒前
知性冰淇淋完成签到,获得积分10
12秒前
ZYX完成签到,获得积分10
13秒前
13秒前
可爱的函函应助zhang采纳,获得10
13秒前
14秒前
14秒前
考拉完成签到 ,获得积分10
14秒前
英俊的铭应助GJJ采纳,获得10
14秒前
16秒前
ljp97发布了新的文献求助10
16秒前
高高的盼山完成签到 ,获得积分10
17秒前
17秒前
fighting发布了新的文献求助10
17秒前
18秒前
贪玩的秋柔应助应用1采纳,获得30
18秒前
妮妮完成签到,获得积分10
18秒前
高分求助中
Cronologia da história de Macau 5000
Matrix Methods in Data Mining and Pattern Recognition 510
Interactions of Vowel Quality and Prosody in East Slavic 500
Vander's Renal Physiology第10版 500
Forensic Science An Introduction to Scientific and Investigative Techniques 6th Edition 400
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
Materials Informatics Molecules, Crystals and Beyond A volume in Acta Materialia Book Series 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7097857
求助须知:如何正确求助?哪些是违规求助? 8754070
关于积分的说明 18515103
捐赠科研通 6653602
什么是DOI,文献DOI怎么找? 3138623
关于科研通互助平台的介绍 2247858
邀请新用户注册赠送积分活动 2113576